Human clinical and epidemiological
studies, in vitro studies, and computer simulators are faster, more reliable,
less expensive, and more humane than animal tests. Comparative studies of human
populations allow doctors and scientists to discover the root causes of human
diseases and disorders so that preventive action can be taken. Epidemiological
studies led to the discoveries of the relationship between smoking and cancer
and to the identification of heart disease risk factors. 2 Population
studies also demonstrated how AIDS and
other infectious diseases are transmitted and
showed how these diseases can be prevented. 3
Cell and tissue culture (in
vitro) studies are used to screen for anti-cancer, anti-AIDS, and other types
of drugs, and are used to produce and
test a number of vaccines, antibiotics,
and therapeutic proteins. In vitro genetic research has isolated
specific markers, genes, and proteins associated with Alzheimer’s disease,
muscular dystrophy, schizophrenia, and other inherited diseases. And today’s "super" computers can
actually predict the effect of substances on all the organs of the human body.
Other promising in vitro methods include microdosing allows precise evaluation of drug activity in the human body using
minuscule drug doses, and the Hurel biochip, which has a series of compartments
lined with cells from various organs, allows a drug to encounter human cells in
the same order it would encounter them in the human body. Biochips from a
specific patient’s cells may soon permit doctors to predict whether a
particular patient can take a specific drug safely and effectively.
Every
year, a new crop of cheaper, faster, more accurate non-animal tests are
developed and put on the market. The American company, MatTek Corporation, makes 3-D tissue models of certain body parts, such eyes or
skin, that come from human cells. For many pharmaceutical companies, these
“living” tissues yield more accurate results than the old, crude tests on
animals. Johnson & Johnson, Procter & Gamble, Unilever, DuPont Co.,
MedImmune Inc. and Nastech Pharmaceutical Co. are a few of the companies that
use MatTek’s tests, and that are investing millions of dollars in non-animal
research .